PL445403A1 - Nowa pochodna 1,3,5-triazyny i jej zastosowanie - Google Patents

Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Info

Publication number
PL445403A1
PL445403A1 PL445403A PL44540323A PL445403A1 PL 445403 A1 PL445403 A1 PL 445403A1 PL 445403 A PL445403 A PL 445403A PL 44540323 A PL44540323 A PL 44540323A PL 445403 A1 PL445403 A1 PL 445403A1
Authority
PL
Poland
Prior art keywords
application
triazine
new derivative
new
derivative
Prior art date
Application number
PL445403A
Other languages
English (en)
Other versions
PL247231B1 (pl
Inventor
Damian Kułaga
Anna Karolina Drabczyk
Izabela SIEMIŃSKA
Original Assignee
Politechnika Krakowska im. Tadeusza Kościuszki
Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Politechnika Krakowska im. Tadeusza Kościuszki, Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie filed Critical Politechnika Krakowska im. Tadeusza Kościuszki
Priority to PL445403A priority Critical patent/PL247231B1/pl
Publication of PL445403A1 publication Critical patent/PL445403A1/pl
Publication of PL247231B1 publication Critical patent/PL247231B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest nowa pochodna tryptamino-1,3,5-triazyny, którą stanowi chlorowodorek benzoesanu(E)-3-((2-(4-((2-(1H-indo-3-ilo)etylo)amino)-6-morfolino-1,2,5-triaz-2-ylo)hydrazono)metylo)fenylu o wzorze 1 do zastosowania w leczeniu nowotworu jelita grubego.
PL445403A 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie PL247231B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL445403A PL247231B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL445403A PL247231B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Publications (2)

Publication Number Publication Date
PL445403A1 true PL445403A1 (pl) 2024-12-30
PL247231B1 PL247231B1 (pl) 2025-06-02

Family

ID=95857911

Family Applications (1)

Application Number Title Priority Date Filing Date
PL445403A PL247231B1 (pl) 2023-06-29 2023-06-29 Nowa pochodna 1,3,5-triazyny i jej zastosowanie

Country Status (1)

Country Link
PL (1) PL247231B1 (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2451802A1 (en) * 2009-07-07 2012-05-16 Pathway Therapeutics, Inc. Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
WO2012083190A1 (en) * 2010-12-17 2012-06-21 The Rockefeller University Insect odorant receptor antagonists

Also Published As

Publication number Publication date
PL247231B1 (pl) 2025-06-02

Similar Documents

Publication Publication Date Title
BR0309427A (pt) Novo uso de um composto (2z)-2-ciano-3-hidroxi-n-[4-(trifluorometil)fenil]-2-hep tano-6-inamida ou 5-(3-butinil)-n-[4-(trifluorometil)fenil]-4-isoxazoleca rbo-amida
CY1124257T1 (el) N-[4-ΦΘOPO-5-[[(2S,4S)-2-MEΘYΛO-4-[(5-MEΘYΛO-1,2,4-ΟΞAΔIAZOΛ-3-YΛO)MEΘOΞY]-l-ΠΙΠΕΡΙΔΥΛΟ]ΜΕΘΥΛΟ]ΘΕΙΑΖΟΛ-2-ΥΛΟ]ΑΚΕΤΑΜΙΔΙΟ ΩΣ ΑΝΑΣΤΟΛΕΑΣ OGA
NZ590268A (en) 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
GEAP202416530A (en) Small molecule inhibitors of ubiquitin specific protease 1 (usp1) and uses thereof
PE20211395A1 (es) Proceso de preparacion de dos derivados de 4-{[(2s)-2-{4-[5-cloro-2-(1h-1,2,3-triazol-1-il)fenil]-5-metoxi-2-oxopiridin-1(2h)-il}butanoil]amino}-2-fluorobenzamida
CY1106521T1 (el) Αναστολεις τυπου 3 αφυδρογονασης 17βητα-υδροξυστepοειδους για τη θepαπεια ασθενειων που εξαρτωνται απο ανδρογονο
NO20044475L (no) 2-(2,6-diklorfenyl)-diarulimidazoler
PE20240143A1 (es) Nuevos derivados de quinazolina como inhibidores de sos1 y uso de los mismos
NZ603525A (en) Pyrimidine based compound and uses thereof
RU2007145935A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
NO20073259L (no) Nye 4-arylaminopyndondenvater som MEK inhibrtorer av hyperproliferende lidelser
BR0308243A (pt) Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero
HRP20050533A2 (en) Aminoindazole derivatives and use thereof as kinase inhibitors
PE20091673A1 (es) Nuevos derivados de carbazol, inhibidores de hsp90, composiciones que los contienen y utilizacion
PT1003725E (pt) Fungicidas de fluoropirazoldifenilamidas
CY1125335T1 (el) Ετεροαρυλικες ενωσεις ως αναστολεας κινασης
MX2010002938A (es) Derivados de (3-hidroxi-4-amino-butan-2-il)-3-(2-tiazol-2-il-pirro lidin-1-carbonil)benzamida y compuestos relacionados como inhibidores de beta-secretasa para tratar enfermedad de alzheimer.
CY1110712T1 (el) Χρηση ν-(3-μεθοξυ-5-μεθυλπυραζιν-2-υλ)-2-(4-[1,3,4-οξαδιαζολ-2-υλ]φαινυλ)πυριδινο-3-σουλφοναμιδης στη θεραπευτικη αντιμετωπιση του καρκινου
IS4593A (is) Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra
EA201070366A1 (ru) 3-метил-2-((2s)-2-(4-(3-метил-1,2,4-оксадиазол-5-ил)фенил)морфолино)-6-(пиримидин-4-ил)пиримидин-4(3н)-он в качестве ингибитора тау-протеинкиназы
EA202191620A1 (ru) Твердые формы, содержащие (s)-4-(4-(4-(((2-(2,6-диоксопиперидин-3-ил)-1-оксоизоиндолин-4-ил)окси)метил)бензил)пиперазин-1-ил)-3-фторбензонитрил и его соли, и содержащие их композиции и способы их применения
CY1109129T1 (el) Χρηση παραγωγων πυρρολιου για καταπολεμηση του αγχους
AR053169A1 (es) Metabolitos de n-2 (cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil) -2-metil -4-pi rimidinil] amino]-5-tiazol carboxamidas
PH12022551282A1 (en) Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
MY129304A (en) Carbamate compounds for use in preventing or treating bipolar disorder